Forced degradation is a crucial aspect of pharmaceutical development, which helps to understand the stability of the drug substance and product. These studies often involve teams working across multiple locations and handling vast amounts of data, which can be challenging to manage and share. This can lead to scientists spending more time on data handling and less time doing science.

Streamline forced degradation research in pharmaceutical development by consolidating all your data into one chemically intelligent platform. Luminata allows researchers to easily access and visualize analytical, chemical, and in silico data from across teams, leading to faster decision-making and improved project management.

Pfizer is taking advantage of Luminata in performing forced degradation research. Dr. Hannah Davies, a Principal Scientist at Pfizer, identified that bringing her data together in one interface facilitates rapid decision-making and supports project management.

See How Luminata’s Forced Degradation Tools Allow You To:

  • Access in silico degradation data from third-party software
  • Create degradation maps from SDFiles
  • Simplify data handling and reduce the risk of errors
  • Support project management and avoid unnecessary duplication of experiments
Sign up to receive more information about Luminata from ACD/Labs
This field is for validation purposes and should be left unchanged.